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Abstract
Background: Gene expression microarray data is notoriously subject to high signal variability.
Moreover, unavoidable variation in the concentration of transcripts applied to microarrays may
result in poor scaling of the summarized data which can hamper analytical interpretations. This is
especially relevant in a systems biology context, where systematic biases in the signals of particular
genes can have severe effects on subsequent analyses. Conventionally it would be necessary to
replace the mismatched arrays, but individual time points cannot be rerun and inserted because of
experimental variability. It would therefore be necessary to repeat the whole time series
experiment, which is both impractical and expensive.
Results: We explain how scaling mismatches occur in data summarized by the popular MAS5
(GCOS; Affymetrix) algorithm, and propose a simple recursive algorithm to correct them. Its
principle is to identify a set of constant genes and to use this set to rescale the microarray signals.
We study the properties of the algorithm using artificially generated data and apply it to
experimental data. We show that the set of constant genes it generates can be used to rescale data
from other experiments, provided that the underlying system is similar to the original. We also
demonstrate, using a simple example, that the method can successfully correct existing
imbalancesin the data.
Conclusion: The set of constant genes obtained for a given experiment can be applied to other
experiments, provided the systems studied are sufficiently similar. This type of rescaling is especially
relevant in systems biology applications using microarray data.
Background
Gene expression profiling using microarrays has become
a popular technique in modern biochemical research.
One of the commonest microarray platforms in use is the
high-density oligonucleotide array introduced by Affyme-
trix (Santa Clara, CA). In the Affymetrix system, bioti-
nylated cRNA generated from the sample of interest is
hybridised to the array and detected using fluorescently-
labelled streptavidin. A number of different expression
summary algorithms are available to derive the concentra-
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tion of each transcript from the intensity of fluorescence.
These include MAS5 (Affymetrix) [1], RMA [2], MBEI
[3,4].
It is important to use the most accurate and precise meth-
ods for calculating gene expression levels from microarray
data. MAS5, RMA and MBEI offer different solutions to
this problem. On Affymetrix arrays, transcripts are repre-
sented by multiple (typically 11) pairs of 25-mer oligonu-
cleotides termed a probeset. One of each pair is a perfect
match (PM) for the target and the other is a mismatch
control (MM). In MAS5, signal values from MM oligonu-
cleotides are subtracted from PM oligonucleotide signals
(if the MM value is greater than the PM value, an "ideal
mismatch" (IM) value is subtracted from the PM value).
RMA and MBEI use only the perfect match signal. In MAS5
there is no attempt to correct non-linearities in the signal
intensity response resulting for example from different
overall transcript concentrations. In other words, MAS5
treats microarrays individually in contrast to RMA and
MBEI, which apply a ranking-type algorithm to arrive at a
signal value, and require multiple microarrays. However,
it is important to note that the nomalization steps applied
at the probe level in both MBEI and RMA even out non-
linearities across microarray experiments, but do not cor-
rect them. The other distinctive characteristic of MAS5 is
that anaysis of spike-in data has shown it to be more accu-
rate than the other methods cited [5,6]. This higher accu-
racy, however, comes at the cost of a lower precision -or
higher variablity- at low expression values. These differ-
ences in method result in differences in performance and
a trade-off between accuracy and precision. Researchers
select their preferred expression summary algorithm
depending on their particular experimental application.
To date, expression profiling has been largely limited to
applications in class discovery or prediction (geared
towards molecular diagnostics), and in relatively simple
functional studies involving direct comparisons of micro-
arrays. Increasingly however, there is a move towards the
mathematical modelling of dynamic gene networks.
These systems biology applications typically require a
sequence of microarray measurements in time which are
applied in conjunction with dynamical models. In this
context, measurement accuracy is paramount otherwise it
would be impossible to arrive at accurate solutions to
kinetic parameter estimates, such as transcript degrada-
tion rates. Therefore in systems biology, the accuracy of
the measurements takes precedence over other considera-
tions such as their precision. The higher accuracy achieved
by MAS5 makes it the method of choice for gene network
modelling.
Systems biology applications also raise practical issues.
Time course data collection is demanding on resources as
replicate RNA samples must be isolated for each time-
point. Because of experimental variability, individual
timepoints cannot be rerun separately. Rejection of data
from outlier arrays in a time course experiment should
therefore entail the replacement of the whole time course.
In complex experimental systems this is often unfeasible
on the grounds of both practicality and cost. Conse-
quently there is a demand for methods for renormalising,
and thus retaining, sub-optimal arrays. These methods
would benefit all microarray applications, but would be
of particular importance where the data is applied in
modeling contexts. In this paper we therefore concentrate
on renormalisation of MAS5 generated data to more accu-
rately reflect expression values.
In MAS5, in order to make microarrays comparable, the
trimmed average of all signals on a microarray is set to
some predefined value. Unlike other methods [2,7], this
simple scaling does not attempt to even out distortions in
signal response (See Figure 1A). A knock-on effect is that,
because the Affymetrix scaling procedure takes into
account almost all the signals on the microarrays, those
genes lying in the median range have a scaling mismatch
(See Figure 1A first panel). Data imbalances that result
become particularly visible in time course applications
(Figure 1B). In this paper, we propose a procedure that
corrects these scaling mismatches. We do not aim to cor-
rect for distortions occurring across the whole signal range
but we rather try to concentrate on those genes whose
intensity is in the median signal range because they are
particularly important in modelling situations. It is also in
this range that scaling mismatches can have have the most
deleterious effects because they are commensurate -if not
bigger- than the measurement error (at low expression
level, measurement errors swamp these scaling mis-
matches). The problem of signal saturation  affecting
strongly expressed genes has been identified and partially
corrected elsewhere [8,9]. In this paper, and for notational
convenience only, we will use the term "gene" in place of
"probe set", even though a given gene can have several
probe sets.
Results and discussion
Our method supposes there exists a set of constant genes,
i.e. genes whose expression levels are unaffected under the
experimental conditions, and that these genes can be used
to accurately normalize the data. This idea of using con-
stant genes has already been proposed [10], it was how-
ever in the context of two-colour cDNA microarrays. Our
method consists of identifying this set of constant genes in
an iterative fashion. In a first step a set of constant genes
is singled out on the basis of some dispersion criteria, we
call this set the initial set. The genes belonging to this set
are used to normalize the microarrays. In a subsequent
step, a new set of unchanging genes is defined using theBMC Bioinformatics 2006, 7:251 http://www.biomedcentral.com/1471-2105/7/251
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Effect of different transcript concentrations illustrated by MvA plots Figure 1
Effect of different transcript concentrations illustrated by MvA plots. A) An MvA plots of mis-scaled data (top) and 
normal data (bottom). In the top plot, the combined effect of non-linear signal response and differences in transcript concen-
tration causes the points to lie in curved region (replicate 2 is the darker microarray, both replicates taken 8 hours after irra-
diation). In contrast, when transcript concentrations are similar the cloud of points is not curved, but aligned with the 
horizontal axis (bottom plot, replicates 1 and 2 for the 0 hours time point). Focusing back to the top plot (region boxed in 
red), one can see how scaling mismatches occur in the median signal range: since the scaling performed in MAS5 takes into 
account almost all the signals, the signals of those genes lying in the median signal range are underscaled on the second chip: the 
median section of the cloud is underneath the horizontal axis. B) The scaling mismatch is even more striking when considering 
a simple time course application using the raw data. Within each replicate, intermediate time points have been linearly interpo-
lated using neighbouring time points (e.g. for the 2 hours time point, the 0 and 4 hours chips have been used). The relative dif-
ference between those interpolation results and the actual values have been computed and the graphs show, for each 
intermediate time point, the first, second, and third quartile of the distribution of these relative differences. The scaling imbal-
ance that occur with non-rescaled data is particularly visible for the 8 hours time point on the second replicate. To see how 
our algorithm corrects this problem, see Figure 6.
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same criteria. Several such steps are performed in
sequence until the set of constant genes is unchanged
from one step to the next. At this point the method is said
to have converged and the corresponding set of constant
probe sets is used to rescale the whole experiment (for a
thorough description see Methods section).
To study the properties of the method, we generated arti-
ficial data. This allowed us to explore its convergence,
increase its efficiency and define criteria for detecting
hypothetical (and unlikely) situations in which a set of
constant genes is non-existent. The results of these purely
in silico explorations are described in the the first part of
this section, the description of the setup is deferred to the
methods section. In the second part, we apply the algo-
rithm to real experimental data and show that it converges
to a unique set of genes and that the set of constant genes
can be re-used with a different microarray dataset, pro-
vided that the tissues involved are sufficiently similar. We
demonstrate, using a simple time course interpolation
example, that the resulting rescaling does indeed correct
imbalances in the data and compare these results with
another popular normalization procedure (quantile nor-
malization) and with RMA-summarized data.
In Silico explorations
Artificial data was generated for 10'000 genes on 7 micro-
arrays, a small portion (5%) of these genes was set to be
constant. The scaling of these data was then perturbed
with varying severity and for each perturbation our rescal-
ing algorithm was applied. This setup is thoroughly
described in the Methods section.
Each individual run was assigned to one of the three fol-
lowing groups:
• Good runs were those for which the size of the final set
exceeded 100.
• In contrast, poor runs were those for which the size of the
final was less than or equal to 100.
• In the special case where the algorithm failed to find a
big enough (> 2) initial set, three genes known to be con-
stant were forced into the initial set (recall that 5% of the
genes were set to be constant). We call these helped runs.
For each run, we computed an accuracy index (see meth-
ods) indicating whether the artificially induced perturba-
tions were accurately corrected. This index can take non-
negative values and must be as close to zero as possible.
We also monitored the speed of convergence, i.e. the
number of iterations steps the algorithm takes before con-
vergence.
Artificial data: results
From this first series of runs we can conclude that the
amount of perturbation affects the speed of convergence,
the bigger the perturbation, the longer it takes for the algo-
rithm to converge (Figure 2, top plot). The number of
steps does not exceed 20, which makes the algorithm
extremely fast (< 1 minute on a standard PC). Secondly,
Algorithm performance for a range of perturbations, with 5%  of constant genes Figure 2
Algorithm performance for a range of perturbations, 
with 5% of constant genes. This series of three plots illus-
trates the performance of the algorithm. Each run of the 
algorithm is represented by a symbol in all three plots. The 
symbol "❍ " represents good runs, "×" represents poor runs 
and "" represents helped runs. In all three plots, the hori-
zontal axis gives the effective perturbation (the average of the 
absolute difference to 1 of all scaling mismatches ka). The 
vertical axis in the top plot is the number of iterations 
required to reach convergence. In the second plot, we 
present the accuracy of the rescaling factors (11). In the bot-
tom plot, the vertical axis gives the size of the final set Um. 
For all the runs represented in those plots, 5% of the genes 
were pre-set to be constant.
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the threshold of 100 used to separate good and poor runs
correctly identifies those runs that yield a good accuracy
(Figure 2, median plot). All good and helped runs, with a
final set size far higher than our set threshold of 100 have
a very good accuracy (< 1%) whereas poor runs, with a
much smaller set size are not accurate. Note also that the
threshold of 100 could have been safely set anywhere
between 50 and 350 (Figure 2, bottom plot).
Helped runs constitute a special case. Despite starting
with a high perturbation – which is why they need help in
the first place – they end up being very similar to good
runs with both a good accuracy and a large final set. The
inclusion of genes known to be constant accelerates con-
vergence so that helped runs converge within 5–7 itera-
tions. Helped runs occur mainly when the perturbation is
large. This demonstrates that feeding some known con-
stant genes into the initial iteration is a good way to
"seed" the algorithm and has the added bonus of speeding
up the (already quick) process. With real data, standard
housekeeping genes (Affymetrix identifier ranging from
20000_s_at to 20099_s_at on the U133 Array) can fulfill
that role.
Although they might not end up in the final set, our expe-
rience is that the inclusion of some of these in the initial
set does indeed set the algorithm onto the right path.
Poor runs were defined by setting a limit on the size of the
final set. For these cases, it is easy to verify that the final
set, on top of being small, has a small "basin of attrac-
tion". We perturbed the initial guess by removing and
adding genes. This produced different final sets thereby
confirming the poor quality of these runs. In contrast,
good and helped runsproduced stable final sets (data not
shown). Hence, poor quality is fairly easy to detect and
can be remedied by supplying the algorithm with a small
set of genes that are suspected of being constant, i.e. to cre-
ate a "helped" run.
In the good and helped runs, the final set of constant
genes contains around 400 genes. Hence, not all constant
genes (recall that 500 of those were generated) are
included in this final set. A less severe selection criterion
would select more constant genes. The final set also
includes a small number of genes (< 10) that were not
expected to be constant. But, as the accuracy plot testifies,
their presence does not have an adverse effect on the final
result. With real data, the boundary between constant and
non-constant genes is blurry, and lightly downregulated
genes are likely to be balanced by lightly upregulated
ones. This hypothesis is also at the heart of the centraliza-
tion algorithm presented in [11].
From this first series of simulations, we conclude that the
quality of a run can simply be assessed by the size of the
final set and that a good way to ensure fast and accurate
convergence is to feed the starting set with genes known to
be constant. In a real situation, standard housekeeping
genes can be used to that effect.
Algorithm performance in the absence of constant genes
In the controlled experiments described above, we set a
small proportion of genes to be constant. To further test
the main features of the algorithm we ran it in the absence
of constant genes, the results are shown in Figure 3. All the
runs are flagged as poor because of the small size of the
final sets. The diversity of these runs is reflected in the vari-
ety of both the size of the final sets and the measured accu-
racies. The latter are all above 10%. Thus, the algorithm
fares badly in the absence of constant genes but this
absence is easily deduced from the lack of a large strongly
attracting final set. With the real experimental data pre-
sented below, this does not happen, and we believe that
in most real situations there should be a sufficiently large
subset of constant genes.
In summary, we recommend including prior information,
by supplying the algorithm with a set of genes known or
likely to be constant. A strong sign that the algorithm has
converged correctly is that the resulting final set is large,
unique and stable, i.e. immune to the inclusion of ran-
dom genes and/or the deletions of genes belonging to it.
Finally, if these properties of the final set are not met, then
this suggests that there are no constant genes. In our expe-
rience, this is unlikely to happen in reality.
Experimental data
Cells from the human T-cell line (MOLT4) were submit-
ted to ionising radiation of 5 Gy using a 137Cs source. RNA
was prepared and labelled using standard procedures.
Affymetrix U133A microarrays were then run on biologi-
cal triplicates of transcripts taken 2,4,6,8,10 and 12 hours
after irradiation. Triplicates were also taken at 0 hours, i.e.
just before irradiation. These 21 microarrays vary in aver-
age signal intensity, by this we mean that some are
"darker" than others, indicating a lower transcript concen-
tration. We will refer to this data set as the 5Gy experi-
ment. Another set of chips were run under different
conditions, the irradiation dose was smaller (1Gy) than in
the previous time series (5Gy). Biological triplicates were
taken 4, 8 and 12 hours after irradiation, the 0 hours
microarrays were the same as in the 5Gy experiment,
therefore there is a slight overlap between the two experi-
ments. This dataset, consisting of 12 microarrays, will be
referred to as the 1Gy experiment. The data was summa-
rized with MAS5 using standard parameters.BMC Bioinformatics 2006, 7:251 http://www.biomedcentral.com/1471-2105/7/251
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5Gy experiment
We first applied the algorithm to the 5Gy experiment. As
a measure of the variability of a gene, we used the second
formula (5) given in the methods section and fixed the
variability limit to 0.2 to match our estimation of the rel-
ative error. This condition was applied to each replicate
separately (if a replicate failed, then the gene would be
excluded from the constant set) rather than globally on
the 21 microarrays.
Further conditions (denoted in the methods section equa-
tion (6) by C(i, A))were as follows:
• To avoid including genes with a low expression and
absent genes an upper limit of 0.001 was set on the detec-
tion p-value provided by MAS5.
• An upper limit on the signal value of the 0 hours micro-
array of the first replicate was set to 2000.
This limit empirically corresponds to the point where dis-
tortions in the upper range of the signal become apparent
(see Figure 1).
The first replicate of the 0 hours microarray was set to be
the reference microarray. The algorithm converged in six
steps to an invariant final set composed of 1194 genes out
of a total of 1675 genes that passed the 0.001 p-value and
2000 intensity filtering. The resulting rescaling factors are
given in Table 1.
To test the stability of the final set, several further runs
were performed using perturbed versions of the original
data. To do this, we chose initial values of   not equal to
1 (  is the initial perturbation coefficient, see methods).
For example,   = 1 + ε, where ε is a random variable uni-
formly distributed on (-1/2,1/2). In all of these additional
runs the algorithm converged to a very similar final set
(the overlap was > 99% in each case), which confirms its
robustness of the original set.
Unsurprisingly, it is the darkest microarrays that require
the most intensive rescaling (replicate 2: 8 hours/replicate
3: 8 and 10 hours): Table 2 below shows the original scal-
ing factors applied by MAS5. However this correlation
breaks down for lower scaling factors. It is important to
stress that our rescaling factors do not replace MAS5's
original scaling factors but complement them. For exam-
ple, the total scaling applied to the raw data obtained
from the microarray run at eight hours (sample 2) is 3.010
* 1.22.
As intended, the expression levels of the genes composing
the constant set span a smaller range than the overall
expression level measured on a microarray (Figure 4).
Note that the majority of gene with signals below 20 are
considered absent by the MAS5 algorithm.
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Algorithm performance for a range of perturbation, with no  constant genes Figure 3
Algorithm performance for a range of perturbation, 
with no constant genes. This series of three plots illus-
trates the performance of the algorithm. Each run of the 
algorithm is represented by a symbol in all three plots. The 
symbol "×" represents poor runs. In all three plots, the hori-
zontal axis gives the effective perturbation (the average of the 
absolute difference to 1 of all scaling mismatches ka). The 
vertical axis in the top plot is the number of iterations 
required to reach convergence. In the second plot, we 
present the accuracy of the rescaling factors (11). In the bot-
tom plot, the vertical axis gives the size of the final set Um. 
This series of plots are obtained through the same process 
shown in Figure 2 except that no genes were forced to be 
constant. In this situation, the algorithm yields only poor 
results, there are no good runs.
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1Gy experiment
Our rescaling algorithm was run with the 1Gy experiment
data set under the same conditions as in the 5Gy experi-
ment, resulting in a set of 1568 constant genes. In this 1Gy
experiment, 2944 genes in total passed the 0.001 p-value
and 2000 signal intensity filtering. The corresponding res-
caling factors are shown in Table 3 below.
With respect to the 5Gy experiment, the quality of the
microarrays used in this second experiment is more uni-
form, which results in rescaling factors that are closer to 1.
Notice as well that the number of genes included in the
constant set is larger: 1568 instead of 1194. This is also
because in the 1Gy experiment there were less microarrays
of lower quality, causing more genes in this experiment to
pass the filtering step.
Lists of constant genes are re-useable
Of the 1568 genes flagged as constant in the 1Gy experi-
ment, 826 are also in the the list of constant genes for the
5Gy experiment (hence 742 genes are included in the 1Gy
list only and 368 in the 5Gy list only). Despite this incom-
plete overlap, we show below that the usage of such lists
does not have to be restricted to the experiments from
which they were extracted.
We found that calculating rescaling factors for the 1Gy
data set using the list of 1194 genes identified though the
5Gy experiment produced values very similar to those
obtained with the 1Gy data alone (Figure 5, right). The
biggest absolute difference between the two sets of values
occurs for the first sample microarray 4 hours after irradi-
ation and is equal to 0.013 (the average of these absolute
differences across all microarrays is equal to 0.005).
The same conclusion can be reached when the experiment
roles are swapped. The rescaling factors for the 5Gy data
obtained using the 1Gy set of constant genes are com-
pared with the original values in Figure 5 (left plot) and
the biggest absolute difference is 0.024 for the third repli-
cate 2 hours after irradiation, the average of these absolute
differences being equal to 0.007.
Therefore, provided that the experimental conditions are
not too dissimilar (same cell line and treatment), we con-
clude that the list of constant genes obtained through a
given experiment can be safely used to calibrate data
obtained from another experiment.
Why is rescaling necessary?
The rescaling factors shown in Table 1 might seem small
with respect to the measurement error that prevails in
microarray experiments and they may have little impact in
simple screening or comparison-type analyses. However,
increasing numbers of microarray experiments are carried
out in a systems biology context (see [12] for a short
review), in which proper scaling of the data is crucial to
obtain sound interpretations.
To illustrate this point, we performed a simple time course
analysis. Intermediate points (at 2,4,6,8 and 10 hours)
were "predicted" using a linear interpolation procedure
on neighbouring time points, for each replicate and gene
(Figure 6). Each plot shows the quartiles of relative inter-
polation error ((true value -interpolated value)/true
value) for the first and the second replicate, before (Figure
6A) and after rescaling (Figure 6B). Non-rescaled data is
severely skewed, this is especially the case for those time
points suffering from ascaling mismatch such as the one
Table 1: Rescaling factors obtained by the recursive procedure 
(5Gy experiment)
s a m p l e  1s a m p l e  2s a m p l e  3
0 hrs 1.00 0.99 0.97
2 hrs 0.98 1.02 1.00
4 hrs 1.04 1.01 0.98
6 hrs 1.04 1.09 1.02
8 hrs 1.00 1.22 1.16
10 hrs 1.08 1.06 1.16
12 hrs 1.03 1.03 1.06
Signal distribution for the set of constant genes, compared to  the overall signal distribution Figure 4
Signal distribution for the set of constant genes, com-
pared to the overall signal distribution. This plot com-
pares the density of the overall distribution of expression in 
the microarray (black) to the one for the constant genes set 
(red). As intended, the distribution range of the constant 
genes set is narrower and centred on the signal range of 
interest. Both density curves are for the second time point (2 
hours after irradiation) of the first replicate.
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illustrated in figure 1 (replicate 2, 8 hours). Rescaling the
data corrects for this mismatch: the interpolation errors
are much more centered in the rescaled situation. We have
used this rescaled data in a modeling context to predict
targets of p53, an important transcription factor involved
in the cell response to DNA damage [13].
We also compared our method to another popular nor-
malization method: quantile normalization [14]. This
normalization step is the one used in the RMA summary
method, albeit at the probe level. We applied it instead to
MAS5 summarized values and the results are shown in fig-
ure 6C. As can be readily seen from this example, quantile
normalization fails to accurately correct for scaling imbal-
ances in the data. Similarly, we performed the same inter-
polation analysis on RMA-summarized probe-level data
(figure 6D). RMA does not perform well in this situation,
we believe this is because the lesser quality microarrays
have a deleterious effect on the whole dataset.
Conclusion
Inaccurate scaling of median range signal values can have
significant deleterious effects on mathematical modelling
of microarray data. Experimental correction of problem-
atic arrays can be expensive and impractical. We have
therefore developed a method for rescaling arrays to avoid
the unnecessary loss of otherwise valid data. We present
an algorithm designed to identify a set of constant genes
in oligonucleotide microarray experiments. Applying this
algorithm to artificially generated data allowed us to iden-
tify the conditions under which this set can be used for the
correction of scaling mismatches. We applied the algo-
rithm successfully to real experimental data and showed
that the set of constant genes obtained for a given experi-
ment can be generally applied, provided the systems stud-
ied are sufficiently similar. This type of rescaling is
especially relevant, if not crucial, in modelling applica-
tions of microarray data.
Methods
Description of the algorithm
Let xi,a be the signal for gene i as it is measured in microar-
ray a. We hypothesise that this value can be decomposed
as follows:
xi,a = kasi,a exp(ε),   (1)
Table 2: Original scaling factors obtained with MAS5
s a m p l e  1s a m p l e  2s a m p l e  3
0 hrs 0.852 0.751 0.931
2 hrs 0.667 0.949 1.925
4 hrs 0.675 1.233 1.019
6 hrs 0.882 1.797 1.732
8 hrs 0.744 3.010 2.634
10 hrs 1.121 1.232 2.364
12 hrs 1.066 1.134 1.688
Rescaling factors obtained with different lists Figure 5
Rescaling factors obtained with different lists. This figure represents the rescaling factors for both sets of microarrays 
each cross represents a microarray. Both 5Gy (A) and 1Gy (B) are shown. The horizontal coordinate gives the rescaling factor 
obtained with the original list and the rescaling factor extracted from the other experiment is given by the vertical coordinate. 
Both sets of rescaling factors are very similar showing that lists of constant genes in one experiment can be re-used in another 
one, provided that the tissues and experimental conditions used are similar.
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Effects of rescaling, quantile normalization and a different summary procedure on subsequent analysis Figure 6
Effects of rescaling, quantile normalization and a different summary procedure on subsequent analysis. Inter-
mediate time points were interpolated using a simple linear procedure using neighbouring time points (for example, the 8 
hours time point was interpolated using the 6 and 10 hours time points). A relative interpolation error was then computed 
from each gene using the formula (XT - XP)/XT where XT is the true value and XP the predicted one. In each plot there are three 
curves which, from top to bottom correspond to the third quartile, median and first quartile of the relative interpolation error. 
This procedure was repeated for each replicate separately before (A), after (B) rescaling, after quantile normalization applied 
on MAS5 summarized values (C) and on RMA summarized data (D). In (B) scaling imbalances have been corrected whilst the 
performance of quantile normalization and RMA summarized data are inferior in that respect (C, D). Only those genes whose 
neighbouring time points have a detection p-value less than or equal to 0.001 were included, which corresponds to 2, 500 – 5, 
000 genes/time point.
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where si,a is the "true" signal for gene i in microarray a (the
value of the signal depends on the microarray as well, but
for purely biological reasons). The third term exp(ε) is a
multiplicative noise term, ε is a random variable identi-
cally distributed across all genes and microarrays with
mean zero, and standard deviation typically around 0.15
– 0.20 which matches the average relative error (of 15% –
20%) generally observed in microarray data. The focus
here is on the first component ka, which results from inac-
curate normalisation. In other words, one wishes to find a
rescaling factor pa such that
paka = 1.
Note that there is no "true" level for the signal, so that a
more accurate formulation would be that one wishes to
find pasuch that paka = C for all microarrays a, where C is
some user-defined constant. However, we will define a
particular microarray r to be the reference (kr = 1) in order
to retain the above formulation.
The proposed algorithm to determine the pa's is simple, it
assumes that there exists a set of genes U whose expression
is unchanged across all microarrays:
U = {i : si,a = si > 0 ∀ a}.
If U is known, an accurate estimate of pa can be obtained
via a ratio of geometric averages for the relevant microar-
rays:
where #(U) denotes the number of elements in the set U.
We show below that   is a good approximation for pa:
 ≈ pa.   (3)
Our aim is to determine U. To do this, we first determine
a set of genes U1 which have a low "variability"  . As a
measure of variability, we could use the coefficient of var-
iation, which is given by
where A is the set A = {1, ..., n} (the set of microarrays),
xi,a, a = 1, ..., n denotes n observations and   is the arith-
metic mean of the xi,a across all a's. We thus average the
readings for a particular gene across several microarrays.
However, because of the multiplicative context, it is pref-
erable to use a geometric average, so that
where   is the geometric mean. We therefore define
U1 = {i : (i, A) <v*   (i, A)},
where A is the set of microarrays and v* is a parameter. 
(i, A) is a boolean variable that denotes another condition
(or set of conditions) on the ith gene and is not of direct
concern here. For example, via   (i, A), we might try and
avoid including in the set of constant genes those genes
that are flagged absent by MAS5 throughout the experi-
ment.
We then assume U1 is U and we use (2) to compute esti-
mated rescaling factors  . The xi,a's can then be updated,
but this is likely to modify the composition of the set con-
stant genes so that we might have to perform a similar step
again, therefore the set U has to be determined in an iter-
ative fashion. The full description of the kth step is
1. Determine a putative set of "constant" genes using
Uk = {i :   (i, A, k - 1) <v*,   (i, A)}.   (6)
In the equation above, a parameter k - 1 has been added
to the function  , to underline the fact that the coeffi-
cient of variation has to be determined with updated val-
ues of the signal.
2. Update the rescaling factors using
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Table 3: Rescaling factors obtained by the recursive procedure 
(1Gy experiment)
Sample 1 Sample 2 Sample 3
0 hrs 1.00 0.99 0.98
4 hrs 1.00 1.03 1.02
8 hrs 1.03 1.07 1.04
12 hrs 1.01 1.04 1.06BMC Bioinformatics 2006, 7:251 http://www.biomedcentral.com/1471-2105/7/251
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or (the formula is equivalent)
3. Update the signals using
or (again, equivalently)
The algorithm has converged at step m if Um and Um+1 are
identical sets. To start the algorithm at k = 1 we require ini-
tial values  . These are given by
 =  xi, a,   (7)
where we will typically fix   = 1.
Several criteria have to be met for the algorithm to be reli-
able. First, one has to verify that the algorithm does con-
verge: it has to find the final set Um and not wander
aimlessly among the huge number of gene sets. Second,
the convergence has to be reasonably quick and robust.
Lastly, one wants to ensure that the final set of genes Um
returned by the algorithm is indeed a set of constant
genes. These conditions are difficult to verify analytically,
which is why we resorted to numeric simulation. These
simulations are presented in the Results and Methods sec-
tion. A R script implementing the algorithm in the case of
simple replication and no extra conditions has been
included as supplementary material.
A set of constant genes can be used for rescaling
We want here to prove that (3) holds and in particular
demonstrate that the approximation is a good one. Using
(1) we have
We have kr = 1, the second ratio on the right hand side is
equal to 1. Turning to the third term in (8), we see that its
expectation can be written as
E (exp (ε)),
where
For the sake of this argument, we assume the relative
errors for the gene expression measurements to be iid and
equal to 20%. Applying the central limit theorem to (9),
one can see that ε is Gaussian with parameters µ = 0 and
a = (2 * 0.2)/ . Thus, exp(ε) is lognormal with the
same parameters. The expectation of a lognormal distribu-
tion is exp(µ + σ2/2), hence
E (exp (ε)) = exp(0 + 0.08/#(U)).
The expectation of this third term is slightly bigger than 1
but since the size on the set U is typically in the hundreds,
the difference is considerably less than 1%. Replacing in
(8) we thus have, as required
where the approximation is more than good enough for
our practical purposes.
In silico explorations
Artificial data generation
We generated artificial signals for 10,000 genes on 7
microarrays using the following procedure. For the ith
gene in the ath microarray we generate observed signals
xi,a according to
xi,a = ka si,a exp(ε),
The first term ka is the scaling mismatch we want the algo-
rithm to uncover. The third term exp(ε) is an error term,
where ε is set to be Gaussian with mean zero and standard
deviation 0.2. The second term si,a is generated using
where   is a Gaussian random variable with mean 1.5
and standard deviation 0.4. Furthermore, a small portion
of these genes (5% or 500) are set to be constant, that is
for i ε U, we have si,a = si.
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Alhough real experiments yield more complex expression
patterns, this artificial data is amply sufficient to capture
the main features of our method.
To simulate the scaling mismatches ka, we generate them
by
ka = 1 + K(u - 0.5),   (10)
where u is a random variable uniformly distributed on the
unit interval and K is a parameter capturing the severity of
the mismatch. Without loss of generality, we set k1 = 1
because choosing an arbitrary reference array is required
by our method.
We generated 191 different datasets and ran the algorithm
on each of them. Each dataset differed from the others by
the choice of the constant K in (10). The 191 values for K
ranged uniformly between 0 and 1.9.
Each run was then assigned to one of the following three
groups on the basis of the size of the final set Um (where
the index m denotes the number of steps it took to the
algorithm to converge):
• Good runs were those for which the size of the final set
Um exceeded 100.
• In contrast, poor runs were those for which the size of Um
was less than or equal to 100.
• In the special case where the algorithm failed to find a
big enough (> 2) initial set U1, three genes known to be
constant were forced into the initial set (recall that 5% of
the genes were set to be constant). We call these helped
runs.
For each run r, we computed an accuracy index using
where pa is the rescaling factor recovered from thealgo-
rithm. Ideally, we want the rescaling factors pa to perfectly
compensate the scaling factors ka so that paka = 1. Conse-
quently, the accuracy index above, which can take non-
negative values, must be as close to zero as possible. We
also monitored the speed of convergence i.e. the number
of iterations steps m the algorithm takes before conver-
gence.
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